We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Legislators Call for Independence for FDA Drug Safety Reviewers
Legislators Call for Independence for FDA Drug Safety Reviewers
May 11, 2010
Members of Congress are calling on the FDA to strengthen the independence of its drug safety evaluators in the wake of a Senate Finance Committee staff report questioning the approval of GlaxoSmithKline’s (GSK) diabetes drug Avandia and an ongoing study comparing it with a generic drug.